Telomeres and telomerase, new targets for anticancer chemotherapy;Télomères et télomérase, de nouvelles cibles pour la chimiothérapie anticancéreuse

Annales Pharmaceutiques Francaises

Volumn 64, Issue 2, 2006, Pages 97-105

  Riou, J F ^a   Morjani, H ^a   Trentesaux, C ^a  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

Author keywords

Chromosome; Chromosome instability; DNA binding proteints; G quadruplex; Single strand telomere; Telomerase; Telomeres

Indexed keywords

ANTINEOPLASTIC AGENT; TELOMERASE; TELOMERASE INHIBITOR; DNA; ENZYME INHIBITOR; LIGAND;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CELL MUTANT; DRUG TARGETING; IN VIVO STUDY; INTRACELLULAR MEMBRANE; PROTEIN EXPRESSION; PROTEIN TARGETING; TARGET CELL DESTRUCTION; TELOMERE; VALIDATION STUDY; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; ENZYMOLOGY; GENETICS; HUMAN; NEOPLASM; PATHOLOGY; REVIEW; ULTRASTRUCTURE;

ANIMALS; ANTINEOPLASTIC AGENTS; DNA, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME INHIBITORS; HUMANS; LIGANDS; NEOPLASMS; TELOMERASE; TELOMERE;

EID: 33646256573     PISSN: 00034509     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4509(06)75301-9     Document Type: Article

References (31)

1. McClintock B. The behavior in successive nuclear divisions of a chromosome broken at meiosis. Proc Natl Acad Sci USA 1939 ; 25 : 405-16.
2. Stewart SA, Weinberg RA. Telomerase and human tumorigenesis. Semin Cancer Biol 2000 ; 10 : 399-406.
3. McEachern MJ, Krauskopf A, Blackburn EH. Telomeres and their control. Annu Rev Genet 2000 ; 34 : 331-58.
4. Mergny JL, Riou JF, Mailliet P, Teulade-Fichou MP, Gilson E. Natural and pharmacological regulation of telomerase. Nucleic Acids Res 2002 ; 30 : 839-65.
5. Lavelle F, Riou JF, Laoui A, Mailliet P. Telomerase : a therapeutic target for the third millennium? Crit Rev Oncol Hematol 2000 ; 34 : 111-26.
6. Smogorzewska A, De Lange T. Regulation of telomerase by telomeric proteins. Annu Rev Biochem 2004 ; 73 : 177-208.
7. Blackburn EH. Switching and signaling at the telomere. Cell 2001 ; 106 : 661-73.
8. Neumann AA, Reddel RR. Telomere maintenance and cancer - look, no telomerase. Nat Rev Cancer 2002 ; 2 : 879-84.
9. Bilaud T, Brun C, Ancelin K, Koering CE, Laroche T, Gilson E. Telomeric localization of TRF2, a novel human telobox protein. Nat Genet 1997 ; 17 : 236-9.
10. Griffith JD, Comeau L, Rosenfield S, Stansel RM, Bianchi A, Moss H et al. Mammalian telomeres end in a large duplex loop. Cell 1999 ; 97 : 503-14.
11. Baumann P, Cech TR. Pot1, the putative telomere end-binding protein in fission yeast and humans. Science 2001 ; 292 : 1171-5.
12. Colgin LM, Baran K, Baumann P, Cech TR, Reddel RR. Human POT1 Facilitates Telomere Elongation by Telomerase. Curr Biol 2003 ; 13 : 942-6.
13. Loayza D, de Lange T. POT1 as a terminal transducer of TRF1 telomere length control. Nature 2003 ; 25 : 25.
14. Riou JF, Gomez D, Mergny JL, Guittat L, Paterski R, Chenais B et al. Régulation de la longueur des télomères : rendre le télomère accessible ? Bull Cancer 2005 ; 92 : 13-22.
15. Zhu XD, Niedernhofer L, Kuster B, Mann M, Hoeijmakers JH, de Lange T. ERCC1/XPF removes the 3′ overhang from uncapped telomeres and represses formation of telomeric DNA-containing double minute chromosomes. Mol Cell 2003 ; 12 : 1489-98.
16. Davies JT. G-quartet 40 years later : from 5′-GMP to molecular biology and supramolecular chemistry. Angew Chem Int Edit 2004 ; 43 : 668-98.
17. Neidle S, Parkinson GN. The structure of telomeric DNA. Curr Opin Struct Biol 2003 ; 13 : 275-83.
18. Riou JF, Gomez D, Lemarteleur T, Trentesaux C. G-quadruplex DNA : myth or reality?. Bull Cancer 2003 ; 90 : 305-13.
19. Gomez D, Mergny JL, Riou JF. Detection of telomerase inhibitors based on G-quadruplex ligands by a modified telomeric repeat amplification protocol assay. Cancer Res 2002 ; 62 : 3365-8.
20. Mergny JL, Lacroix L, Teulade-Fichou MP, Hounsou C, Guittat L, Hoarau M et al. Telomerase inhibitors based on quadruplex ligands selected by a fluorescence assay. Proc Natl Acad Sci USA 2001 ; 98 : 3062-7.
21. Riou JF, Guittat L, Mailliet P, Laoui A, Renou E, Petitgenet O et al. Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands. Proc Natl Acad Sci USA 2002 ; 99 : 2672-7.
22. Koeppel F, Riou JF, Laoui A, Mailliet P, Arimondo PB, Labit D et al. Ethidium derivatives bind to G-quartets, inhibit telomerase and act as fluorescent probes for quadruplexes. Nucleic Acids Res 2001 ; 29 : 1087-96.
23. Pennarun G, Granotier C, Gauthier LR, Gomez D, Hoffschir F, Mandine E et al. Apoptosis related to telomere instability and cell cycle alterations in human glioma cells treated by new highly selective G-quadruplex ligands. Oncogene 2005 ; 24 : 2917-28.
24. Lemarteleur T, Gomez D, Paterski R, Mandine E, Mailliet P, Riou JF. Stabilization of the c-myc gene promoter quadruplex by specific ligands inhibitors of telomerase. Biochem Biophys Res Commun 2004 ; 323 : 802-8.
25. Gomez D, Aouali N, Renaud A, Douarre C, Shin-Ya K, Tazi J et al. Resistance to senescence induction and telomere shortening by a G-quadruplex ligand inhibitor of telomerase. Cancer Res 2003 ; 63 : 6149-53.
26. Gomez D, Aouali N, Londono-Vallejo A, Lacroix L, Megnin-Chanet F, Lemarteleur T et al. Resistance to the Short Term Antiproliferative Activity of the G-quadruplex Ligand 12459 Is Associated with Telomerase Overexpression and Telomere Capping Alteration. J Biol Chem 2003 ; 278 : 50554-62.
27. Siddiqui-Jain A, Grand CL, Bearss DJ, Hurley LH. Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription. Proc Natl Acad Sci USA 2002 ; 99 : 11593-8.
28. Gomez D, Lemarteleur T, Lacroix L, Mailliet P, Mergny JL, Riou JF. Telomerase downregulation induced by the G-quadruplex ligand 12459 in A549 cells is mediated by hTERT RNA alternative splicing. Nucleic Acids Res 2004 ; 32 : 371-9.
29. Shin-Ya K, Wierzba K, Matsuo K, Ohtani T, Yamada Y, Furihata K et al. Telomestatin, a novel telomerase inhibitor from Streptomyces anulatus. J Am Chem Soc 2001 ; 123 : 1262-3.
30. Cimino-Reale G, Pascale E, Battiloro E, Starace G, Verna R, D'Ambrosio E. The length of telomeric G-rich strand 3′-overhang measured by oligonucleotide ligation assay. Nucleic Acids Res 2001 ; 29 : E35.
31. Gomez D, Paterski R, Lemarteleur T, Shin-Ya K, Mergny JL, Riou JF. Interaction of telomestatin with the telomeric single-strand overhang. J Biol Chem 2004 ; 279 : 41487-94.